Mu-Opioid receptors modulate noradrenaline release from the rat hippocampus as measured by brain microdialysis
dc.contributor.author | Matsumoto, Machiko | en_US |
dc.contributor.author | Yoshioka, Mitsuhiro | en_US |
dc.contributor.author | Togashi, Hiroko | en_US |
dc.contributor.author | Hirokami, Mitsugu | en_US |
dc.contributor.author | Tochihara, Masahiro | en_US |
dc.contributor.author | Ikeda, Toshiya | en_US |
dc.contributor.author | Smith, Charles B. | en_US |
dc.contributor.author | Saito, Hideya | en_US |
dc.date.accessioned | 2006-04-10T18:20:59Z | |
dc.date.available | 2006-04-10T18:20:59Z | |
dc.date.issued | 1994-02-04 | en_US |
dc.identifier.citation | Matsumoto, Machiko, Yoshioka, Mitsuhiro, Togashi, Hiroko, Hirokami, Mitsugu, Tochihara, Masahiro, Ikeda, Toshiya, Smith, Charles B., Saito, Hideya (1994/02/04)."Mu-Opioid receptors modulate noradrenaline release from the rat hippocampus as measured by brain microdialysis." Brain Research 636(1): 1-8. <http://hdl.handle.net/2027.42/31782> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6SYR-483626P-2B9/2/ba17aa33220a40fff79fc5371464d575 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/31782 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=8156397&dopt=citation | en_US |
dc.description.abstract | The modulation of noradrenaline (NA) release via presynaptic opioid receptors in the hippocampus of freely moving rats was studied by the use of brain microdialysis. Extracellular levels of NA were estimated by assaying its concentrations in the perfusion fluid using high-performance liquid chromatography (HPLC) with electrochemical detection (ECD). Spontaneous NA levels were reduced by tetrodotoxin (1 [mu]M) co-perfusion and were increased by peripheral administration of desipramine (5 and 10 mg/kg, i.p.). Addition of potassium (K+, 60 and 120 mM) to the perfusion fluid evoked a concentration-dependent release of NA. K+ (120 mM)-evoked NA release was markedly reduced by removal of calcium (Ca2+) from the perfusion fluid. These results indicate that both the spontaneous and the K+-evoked NA release measured by the use of brain microdialysis coupled with HPLC-ECD can be used as indices of neuronal release from the noradrenergic nerve terminals. A [mu]-opioid receptor agonist, morphine (0.01-10 [mu]M), when co-perfused with K+ (120 mM), produced a reduction of K+-evoked NA release in a concentration-dependent manner. Neither co-perfusion with a high concentration of [-Pen2, -Pen5]-enkephalin (DPDPE) (10 [mu]M), an agonist selective for [delta]-opioid receptors, nor with U-69593 (10 [mu]M), an agonist selective for [kappa]-opioid receptors, modified the K+ (120 mM)-evoked release of NA. Morphine-induced (1 [mu]M) inhibition of NA release was blocked by a [mu]-opioid receptor antagonist, naltrexone (3 and 9 mg/kg, i.p). Naltrexone by itself did not alter the spontaneous NA levels or the K+-evoked NA release. The morphine-induced (1 [mu]M) inhibition of NA release was abolished by pretreatment with pertussis toxin (PTX) that was perfused into the hippocampus by push-pull cannulation. These findings suggest that NA release is functionally modulated via the [mu]-opioid receptors located on noradrenergic nerve terminals in the rat hippocampus. It indicates, furthermore, the possibility that the inhibition of NA release via the [mu]-opioid receptors is linked to G-proteins which are substrates of PTX. | en_US |
dc.format.extent | 754497 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Mu-Opioid receptors modulate noradrenaline release from the rat hippocampus as measured by brain microdialysis | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbsecondlevel | Molecular, Cellular and Developmental Biology | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pharmacology, University of Michigan Medical School, Ann Arbor, MI 48109-0626, USA | en_US |
dc.contributor.affiliationother | First Department of Pharmacology, Hokkaido University School of Medicine, Kita-15, Nishi-7, Kita-ku, Sapporo 060, Japan | en_US |
dc.contributor.affiliationother | First Department of Pharmacology, Hokkaido University School of Medicine, Kita-15, Nishi-7, Kita-ku, Sapporo 060, Japan | en_US |
dc.contributor.affiliationother | First Department of Pharmacology, Hokkaido University School of Medicine, Kita-15, Nishi-7, Kita-ku, Sapporo 060, Japan | en_US |
dc.contributor.affiliationother | First Department of Pharmacology, Hokkaido University School of Medicine, Kita-15, Nishi-7, Kita-ku, Sapporo 060, Japan | en_US |
dc.contributor.affiliationother | First Department of Pharmacology, Hokkaido University School of Medicine, Kita-15, Nishi-7, Kita-ku, Sapporo 060, Japan | en_US |
dc.contributor.affiliationother | First Department of Pharmacology, Hokkaido University School of Medicine, Kita-15, Nishi-7, Kita-ku, Sapporo 060, Japan | en_US |
dc.contributor.affiliationother | First Department of Pharmacology, Hokkaido University School of Medicine, Kita-15, Nishi-7, Kita-ku, Sapporo 060, Japan | en_US |
dc.identifier.pmid | 8156397 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/31782/1/0000723.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0006-8993(94)90169-4 | en_US |
dc.identifier.source | Brain Research | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.